Morning Overview on MSN
One breach this month exposed clinical-trial patients’ IDs and health data
Clinical-trial patients whose records were stored on a CareCloud electronic health-record system now face an open question about whether their identifiers and health data were stolen. CareCloud, Inc.
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
Novo Nordisk (NYSE:NVO) has disclosed a patient data breach affecting individuals involved in its clinical trials. The company is assessing the scope of the data exposure and potential regulatory ...
Abstract recently submitted in anticipation of initial data analysis ahead of ESC Company expects to report topline LEVEL ...
Progression from F3 to cirrhosis occurred in roughly one year, contrasting STELLAR’s 13% over four years and suggesting trials may underrepresent real-world risk. Among compensated cirrhosis, 29.7% ...
Two innovative, forward-thinking organizations show how rebuilding patient trust is becoming the real breakthrough driving ...
In the last decade, the volume of clinical trial data has surged, presenting unprecedented challenges for sponsors and contract research organizations (CROs). The task of collecting, cleaning, ...
A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has synergized the impacts of worldwide ...
Why is tokenization important for the future of medicine development? A tremendous amount of data is collected throughout a clinical trial, but prior to tokenization, the life science industry did not ...
This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Clinical trials represent a significant ...
Faculty in this hub lead the design, coordination, and analysis of clinical trials for cancer treatment, survivorship, vaccine efficacy, infectious disease prevention and treatment, and cancer ...
Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results